Sangcopan, Saidah .
HRN: 28-08-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
CEFUROXIME 1.5GM (VIAL)
12/17/2025
12/18/2025
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary LSTCS + IUD
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes